Concepedia
Statistics
Publications
7
Citations
200
H-Index
Active since
1994
Affiliations
Pfizer (United States)(Current)
University of Kansas
Amy S. Antipas is an author at Pfizer (United States) specializing in pharmacy, pharmacology, and molecular pharmacology.
Publications per year
1994–2013
Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs
Paul Nkansah, Amy S. Antipas, Ying Lü et al. · Journal of Controlled Release · 2013 · 61 citations
Pharmacy, Pharmaceutics, Pharmacology +16
Potent, selective pyrimidinetrione-based inhibitors of MMP-13
Lawrence A. Reiter, Kevin D. Freeman‐Cook, Christopher S. Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13
Kevin D. Freeman‐Cook, Lawrence A. Reiter, Mark C. Noe et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
Effect of Conformation on the Rate of Deamidation of Vancomycin in Aqueous Solutions
Amy S. Antipas, David G. Vander Velde, Seetharama D. Jois et al. · Journal of Pharmaceutical Sciences · 2000 · 22 citations
Pharmacy, Pharmaceutics, Pharmacokinetics +7
Factors affecting the deamidation of vancomycin in aqueous solutions
Amy S. Antipas, David Vander Velde, V.J. Stella · International Journal of Pharmaceutics · 1994 · 18 citations
Pharmacy, Pharmaceutics, Bioavailability +7
1–5 of 7